Drug Profile
Lyme disease vaccine - GSK
Alternative Names: LYMErixLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Nonindustrial source; Yale University
- Developer Nonindustrial source
- Class Bacterial vaccines; Lyme disease vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Lyme disease